249 related articles for article (PubMed ID: 32237925)
1. Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017.
Fabiani M; Volpe E; Faraone M; Bella A; Pezzotti P; Chini F
Expert Rev Vaccines; 2020 May; 19(5):479-489. PubMed ID: 32237925
[TBL] [Abstract][Full Text] [Related]
2. Determinants of vaccination uptake, and influenza vaccine effectiveness in preventing deaths and hospital admissions in the elderly population; Treviso, Italy, 2014/2015-2016/2017 seasons.
Bellino S; Piovesan C; Bella A; Rizzo C; Pezzotti P; Ramigni M
Hum Vaccin Immunother; 2020; 16(2):301-312. PubMed ID: 31486347
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.
Gasparini R; Amicizia D; Lai PL; Rossi S; Panatto D
Hum Vaccin Immunother; 2013 Jan; 9(1):144-52. PubMed ID: 23143775
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season.
Bella A; Gesualdo F; Orsi A; Arcuri C; Chironna M; Loconsole D; Napoli C; Orsi GB; Manini I; Montomoli E; Alfonsi V; Castrucci MR; Rizzo C
Expert Rev Vaccines; 2019 Jun; 18(6):671-679. PubMed ID: 31159616
[No Abstract] [Full Text] [Related]
5. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
Domnich A; Arata L; Amicizia D; Puig-Barberà J; Gasparini R; Panatto D
Vaccine; 2017 Jan; 35(4):513-520. PubMed ID: 28024956
[TBL] [Abstract][Full Text] [Related]
6. Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza Season.
Imran M; Puig-Barbera J; Ortiz JR; Lopez-Gonzalez L; Dean A; Bonafede M; Haag MDM
Influenza Other Respir Viruses; 2024 Apr; 18(4):e13288. PubMed ID: 38644564
[TBL] [Abstract][Full Text] [Related]
7. MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.
Puig-Barberà J; Natividad-Sancho A; Calabuig-Pérez J; Lluch-Rodrigo JA; Pastor-Villalba E; Martínez-Úbeda S; Pérez-Vilar S; Díez-Domingo J
Vaccine; 2013 Aug; 31(37):3995-4002. PubMed ID: 23731629
[TBL] [Abstract][Full Text] [Related]
8. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
[TBL] [Abstract][Full Text] [Related]
11. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
Leval A; Hergens MP; Persson K; Örtqvist Å
Euro Surveill; 2016 Oct; 21(43):. PubMed ID: 27813473
[TBL] [Abstract][Full Text] [Related]
12. Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study.
Spadea A; Unim B; Colamesta V; Meneghini A; D'Amici AM; Giudiceandrea B; La Torre G
Vaccine; 2014 Sep; 32(41):5290-4. PubMed ID: 25087677
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
Ridenhour BJ; Campitelli MA; Kwong JC; Rosella LC; Armstrong BG; Mangtani P; Calzavara AJ; Shay DK
PLoS One; 2013; 8(10):e76318. PubMed ID: 24146855
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
van Aalst R; Gravenstein S; Mor V; Mahmud SM; Wilschut J; Postma M; Chit A
Vaccine; 2020 Jan; 38(2):372-379. PubMed ID: 31606249
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic evaluation of the MF59--adjuvanted influenza vaccine in the elderly population in Italy.
Iannazzo S
J Prev Med Hyg; 2011 Mar; 52(1):1-8. PubMed ID: 21710816
[TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.
Szilagyi PG; Fairbrother G; Griffin MR; Hornung RW; Donauer S; Morrow A; Altaye M; Zhu Y; Ambrose S; Edwards KM; Poehling KA; Lofthus G; Holloway M; Finelli L; Iwane M; Staat MA;
Arch Pediatr Adolesc Med; 2008 Oct; 162(10):943-51. PubMed ID: 18838647
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly.
Lapi F; Marconi E; Simonetti M; Baldo V; Rossi A; Sessa A; Cricelli C
Expert Rev Vaccines; 2019 Jun; 18(6):663-670. PubMed ID: 31155968
[No Abstract] [Full Text] [Related]
18. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
Nunzi E; Iorio AM; Camilloni B
Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18.
Zhang D; Zhang Y; Wang Q; Lock J; Pan Y; Cui S; Yang P; Hu Y
Vaccine; 2019 Mar; 37(13):1853-1858. PubMed ID: 30827734
[TBL] [Abstract][Full Text] [Related]
20. Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19.
Pebody R; Whitaker H; Zhao H; Andrews N; Ellis J; Donati M; Zambon M
Vaccine; 2020 Jan; 38(2):173-179. PubMed ID: 31653528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
